EMBL Ventures Overview

  • Investor Type
  • Venture Capital

  • Status
  • Active

  • Professionals
  • 4

Professionals

  • Investments
  • 45

  • Portfolio
  • 7

  • Exits
  • 24

Exits

EMBL Ventures General Information

Description

Founded in 2001, EMBL Ventures is a venture capital firm based in Heidelberg, Germany. The firm prefers to invest in the biotechnology, medical technology, and life-science sectors across Europe.

Contact Information

Website
www.embl-ventures.com
Year Founded
2001
Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Primary Office
  • Boxbergring 107
  • 69126 Heidelberg
  • Germany
+49 06221 000000

EMBL Ventures Investments (45)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Topas Therapeutics 02-Jul-2021 Later Stage VC 000.00 Drug Discovery Clinical Trials - Phase 2 000000 0000 00.0
0000 0000000 01-Apr-2019 0000 00000 Other Devices and Supplies Generating Revenue
000000000 00000000 30-Apr-2018 00000 00000 000.00 Drug Discovery Generating Revenue 00000 0000 00.0
00000 000000000000 18-Jan-2018 00000 00000 000.00 Drug Discovery Clinical Trials - Phase 2 000 00000 00.0
0000000 0000000000 04-Dec-2017 00000 00000 000.00 Drug Discovery Generating Revenue
000000000 00000000 26-Jun-2017 00000 00000 000.00 Biotechnology Generating Revenue
0000000 05-May-2017 00000 00000 000.00 Biotechnology Generating Revenue 000 00000 00.0
0000000 12-Jan-2017 00000 00000 00.000 Diagnostic Equipment Generating Revenue 000000 0000 00.0
ViraTherapeutics 28-Oct-2016 Early Stage VC 00.000 Drug Discovery Generating Revenue
ImevaX 27-Sep-2016 Early Stage VC 00.000 Diagnostic Equipment Clinical Trials - Phase 1 000000 0000 00.0
You’re viewing 10 of 45 investments. Get the full list »

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

EMBL Ventures Exits (24)

Company Name Exit Date Exit Type Exit Size
ACQUIFER 05-Jan-2023 Merger/Acquisition
000000 01-Apr-2021 000000000 00000000
00000000 00000000 12-Mar-2021 000000000000000000 00000
00000000 02-Jul-2020 0000000 000000 00000
00000 000000000000 01-Nov-2019 0000000000: 000000
000000 00000000000 13-Jan-2019 0000000000: 000000
0000000000000000 13-Sep-2018 000000000000000000 00000
0000000 16-Nov-2017 000 0000
Apellis Pharmaceuticals 09-Nov-2017 IPO 00000
Miltenyi Biotec (Germany) 31-May-2017 Merger/Acquisition
You’re viewing 10 of 24 exits. Get the full list »

EMBL Ventures Fund Performance

Fund Name Vintage Size Dry Powder DPI RVPI TVPI IRR

This information is available in the PitchBook Platform. To explore EMBL Ventures‘s full profile, request access.

Request a free trial

EMBL Ventures Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

EMBL Ventures Team (13)

Name Title Deals Funds Boards Office
Stefan Herr Ph.D Founder, Partner & Managing Director 0 0 0 Heidelberg, Germany
Heinz Schwer Ph.D Partner & Managing Director 0 Heidelberg, Germany
Rainer Wessel Ph.D Venture Partner Heidelberg, Germany
Caroline Lehmann Ph.D Partner Heidelberg, Germany
Karolina Sobko Executive, Finance Heidelberg, Germany
You’re viewing 5 of 13 team members. Get the full list »

EMBL Ventures Co-Investors (7)

Name With Exits Lead Partner Series Industry
BioMedPartners 1 0 Series chart Industry bar
Epidarex Capital 0 0 Series chart Industry bar
Evotec 0 0 Series chart Industry bar
Gimv 0 0 Series chart Industry bar
Vesalius Biocapital Partners 0 0 Series chart Industry bar
You’re viewing 5 of 7 co-investors. Get the full list »